Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?

What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution? Health Policy. 1998 Jun; 44(3):253-60.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.